Patient Pathfinder: Clinical Trials
Clinical Trials for Lung Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 978 active Lung Cancer trials
Reminder Messages for Lung Cancer Screening
Study Type: Observational
Project PLUS Lung Cancer Screening Promotion
Study Type: Interventional
Observational Basket Trial to Predict Response to Immune Checkpoint Inhibitors Across Solid Tumors
Study Type: Observational
The Neuroendocrine Effects of Pioglitazone in Patients With Lung Cancer and Cachexia
Study Type: Interventional Phase 2
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
Study Type: Interventional Phase 2
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
Study Type: Interventional Phase 2
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Study Type: Interventional Phase 3
There are 978 active Lung Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now